Repeated Courses of Escalating Doses of Nivolumab in Refractory Hodgkin Lymphoma with Recurrent Relapses Post Allografting: A Safe and Effective Treatment Approach.
Hematology Reports（2021）
Key words
allogeneic hematopoietic stem cell transplantation,Hodgkin lymphoma,programmed death-1 (PD-1) inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined